BIOMAT Database Logo BIOMAT Database Logo

First-trimester screening for trisomy 21 using alpha-fetoprotein. 2011

Foteini E Bredaki, and David Wright, and Pedro Matos, and Argyro Syngelaki, and Kypros H Nicolaides
Harris Birthright Research Centre of Fetal Medicine, King's College Hospital, London, UK.

OBJECTIVE To investigate the potential value of adding maternal serum alpha-fetoprotein (AFP) to free β-human chorionic gonadotropin (β-hCG) and PAPP-A and fetal nuchal translucency (NT) thickness in first-trimester screening for trisomy 21. METHODS In this case control study, serum AFP was measured in 100 trisomy 21 and 1,500 euploid pregnancies in which screening for trisomy 21 had been performed by a combination of serum free β-hCG and PAPP-A and fetal NT at 11-13 weeks' gestation. We examined the effect of adding AFP on the performance of screening by the combined test. RESULTS In the trisomy 21 pregnancies, the median multiple of the normal median AFP, adjusted for gestational age, maternal weight, racial origin, smoking status and method of conception, was significantly reduced (0.7037, 95% CI: 0.6398-0.7739). Adding AFP to the combined test improved the performance of screening and for a risk cut-off of 1 in 100, the false-positive rate was reduced from 2.8 by 0.4% (95% CI: 0.13-0.77%) without a significant change in detection rate. CONCLUSIONS Inclusion of serum AFP improves the performance of the first-trimester combined test in screening for trisomy 21.

UI MeSH Term Description Entries
D008423 Maternal Age The age of the mother in PREGNANCY. Age, Maternal,Ages, Maternal,Maternal Ages
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D011261 Pregnancy Trimester, First The beginning third of a human PREGNANCY, from the first day of the last normal menstrual period (MENSTRUATION) through the completion of 14 weeks (98 days) of gestation. Early Placental Phase,Pregnancy, First Trimester,Trimester, First,Early Placental Phases,First Pregnancy Trimester,First Pregnancy Trimesters,First Trimester,First Trimester Pregnancies,First Trimester Pregnancy,First Trimesters,Phase, Early Placental,Phases, Early Placental,Placental Phase, Early,Placental Phases, Early,Pregnancies, First Trimester,Pregnancy Trimesters, First,Trimesters, First
D011266 Pregnancy-Associated Plasma Protein-A A product of the PLACENTA, and DECIDUA, secreted into the maternal circulation during PREGNANCY. It has been identified as an IGF binding protein (IGFBP)-4 protease that proteolyzes IGFBP-4 and thus increases IGF bioavailability. It is found also in human FIBROBLASTS, ovarian FOLLICULAR FLUID, and GRANULOSA CELLS. The enzyme is a heterotetramer of about 500-kDa. PAPP-A,IGFBP-4 Metalloproteinase,IGFBP-4 Protease,IGFBP-4-Specific Proteinase,Insulin-Like Growth Factor-Dependent IGF Binding Protein-4 Protease,Insulin-Like-Growth Factor Binding Protein-4 Protease,PAPP-alpha,Pregnancy Associated alpha Plasma Protein,Pregnancy-Associated alpha-Plasma Protein,IGFBP 4 Metalloproteinase,IGFBP 4 Protease,Insulin Like Growth Factor Binding Protein 4 Protease,Insulin Like Growth Factor Dependent IGF Binding Protein 4 Protease,Metalloproteinase, IGFBP-4,PAPP alpha,Pregnancy Associated Plasma Protein A,Protease, IGFBP-4
D011296 Prenatal Diagnosis Determination of the nature of a pathological condition or disease in the postimplantation EMBRYO; FETUS; or pregnant female before birth. Diagnosis, Prenatal,Fetal Diagnosis,Fetal Imaging,Fetal Screening,Intrauterine Diagnosis,Antenatal Diagnosis,Antenatal Screening,Diagnosis, Antenatal,Diagnosis, Intrauterine,Prenatal Screening,Antenatal Diagnoses,Antenatal Screenings,Diagnosis, Fetal,Fetal Diagnoses,Fetal Imagings,Fetal Screenings,Imaging, Fetal,Intrauterine Diagnoses,Prenatal Diagnoses,Prenatal Screenings,Screening, Antenatal,Screening, Fetal,Screening, Prenatal
D004314 Down Syndrome A chromosome disorder associated either with an extra CHROMOSOME 21 or an effective TRISOMY for chromosome 21. Clinical manifestations include HYPOTONIA, short stature, BRACHYCEPHALY, upslanting palpebral fissures, epicanthus, Brushfield spots on the iris, protruding tongue, small ears, short, broad hands, fifth finger clinodactyly, single transverse palmar crease, and moderate to severe INTELLECTUAL DISABILITY. Cardiac and gastrointestinal malformations, a marked increase in the incidence of LEUKEMIA, and the early onset of ALZHEIMER DISEASE are also associated with this condition. Pathologic features include the development of NEUROFIBRILLARY TANGLES in neurons and the deposition of AMYLOID BETA-PROTEIN, similar to the pathology of ALZHEIMER DISEASE. (Menkes, Textbook of Child Neurology, 5th ed, p213) Mongolism,Trisomy 21,47,XX,+21,47,XY,+21,Down Syndrome, Partial Trisomy 21,Down's Syndrome,Partial Trisomy 21 Down Syndrome,Trisomy 21, Meiotic Nondisjunction,Trisomy 21, Mitotic Nondisjunction,Trisomy G,Downs Syndrome,Syndrome, Down,Syndrome, Down's
D005189 False Positive Reactions Positive test results in subjects who do not possess the attribute for which the test is conducted. The labeling of healthy persons as diseased when screening in the detection of disease. (Last, A Dictionary of Epidemiology, 2d ed) False Positive Reaction,Positive Reaction, False,Positive Reactions, False,Reaction, False Positive,Reactions, False Positive
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000509 alpha-Fetoproteins The first alpha-globulins to appear in mammalian sera during FETAL DEVELOPMENT and the dominant serum proteins in early embryonic life. alpha-Fetoprotein,alpha Fetoprotein,alpha Fetoproteins

Related Publications

Foteini E Bredaki, and David Wright, and Pedro Matos, and Argyro Syngelaki, and Kypros H Nicolaides
First trimester biochemical screening for trisomy 21.
September 1995, Annals of clinical biochemistry,
Foteini E Bredaki, and David Wright, and Pedro Matos, and Argyro Syngelaki, and Kypros H Nicolaides
First-trimester screening for neural tube defects using alpha-fetoprotein.
January 2012, Fetal diagnosis and therapy,
Foteini E Bredaki, and David Wright, and Pedro Matos, and Argyro Syngelaki, and Kypros H Nicolaides
Nasal bone in first-trimester screening for trisomy 21.
July 2006, American journal of obstetrics and gynecology,
Foteini E Bredaki, and David Wright, and Pedro Matos, and Argyro Syngelaki, and Kypros H Nicolaides
First-trimester alpha-fetoprotein screening for Down syndrome.
March 1993, Prenatal diagnosis,
Foteini E Bredaki, and David Wright, and Pedro Matos, and Argyro Syngelaki, and Kypros H Nicolaides
Second-trimester genetic sonography after first-trimester combined screening for trisomy 21.
March 2009, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine,
Foteini E Bredaki, and David Wright, and Pedro Matos, and Argyro Syngelaki, and Kypros H Nicolaides
First trimester biochemical screening for trisomy 21: the role of free beta hCG, alpha fetoprotein and pregnancy associated plasma protein A.
September 1994, Annals of clinical biochemistry,
Foteini E Bredaki, and David Wright, and Pedro Matos, and Argyro Syngelaki, and Kypros H Nicolaides
[Alpha-fetoprotein and trisomy 21].
August 1988, Journal de genetique humaine,
Foteini E Bredaki, and David Wright, and Pedro Matos, and Argyro Syngelaki, and Kypros H Nicolaides
Diagnostic value of maternal alpha-fetoprotein variants in second-trimester biochemical screening for trisomy 21 and 18.
August 2022, Scientific reports,
Foteini E Bredaki, and David Wright, and Pedro Matos, and Argyro Syngelaki, and Kypros H Nicolaides
Prospective validation of first-trimester combined screening for trisomy 21.
July 2009, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology,
Foteini E Bredaki, and David Wright, and Pedro Matos, and Argyro Syngelaki, and Kypros H Nicolaides
Prospective first-trimester screening for trisomy 21 in 30,564 pregnancies.
June 2005, American journal of obstetrics and gynecology,
Copied contents to your clipboard!